Arylsulfonamides as antiviral agents

US7115612B2 · kind B2 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Tobias Wunberg · Mödling, AT
• Wolfgang Bender · Wuppertal, DE
• Peter Eckenberg · Wuppertal, DE
• Sabine Hallenberger · Wuppertal, DE
• Kerstin Henninger · Wuppertal, DE
• Jörg Keldenich · Wuppertal, DE
• Armin Kern · Wuppertal, DE
• Siegfried Raddatz · Hanerau-Hademarschen, DE
• Jurgen Reefschlager · Oldenburg, DE
• Gunter Schmidt · Houghton, US
• Holger Zimmermann · Falkensee, DE
• Franz Zumpe · Wuppertal, DE
• Martin Radtke · Erkrath, DE

Key dates

• Filing date: Apr 8, 2002
• Grant date: Oct 3, 2006
• Expiry date: Dec 23, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to novel sulphonamides of the general formula (I)in which the substituents R1, R2, R3, R4 and A and X are as defined in claim 1 and other claims, and also to processes for their preparation and to their use as antiviral agents, in particular against cytomegaloviruses.